Expertise
Design Development
Manufacturing
Injection moulding
Assembly
Packaging
Filling
Development on request
Devices
Connected devices
Pharmaceutical Devices
Who are we
Our values
Our history
Our team
Career opportunities
Certifications / They trust us
Media
Press releases
News
Contact
Contact
Legal notice
Cookies
EN
FR
Expertise
Design Development
Manufacturing
Injection moulding
Assembly
Packaging
Filling
Development on request
Devices
Connected devices
Pharmaceutical Devices
Who are we
Our values
Our history
Our team
Career opportunities
Certifications / They trust us
Media
Press releases
News
Contact
Contact
Legal notice
Cookies
EN
FR
January 2023
2023 financial calendar
230105 PR_BIOCORP
BIOCORP completes a €2.5 million convertible bond issue subscribed by funds managed by Vatel Capital
230102 PR BIOCORP
Biocorp is now a Novo Nordisk company
Click here for more information
or send a mail